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Abstract
There has been strong recent interest in testing interval null hypothesis for improved scientific infer-
ence. For example, Lakens et al (2018) and Lakens and Harms (2017) use this approach to study if there
is a pre-specified meaningful treatment effect in gerontology and clinical trials, which is different from
the more traditional point null hypothesis that tests for any treatment effect. Two popular Bayesian ap-
proaches are available for interval null hypothesis testing. One is the standard Bayes factor and the other
is the Region of Practical Equivalence (ROPE) procedure championed by Kruschke and others over many
years. This paper establishes a formal connection between these two approaches with two benefits. First,
it helps to better understand and improve the ROPE procedure. Second, it leads to a simple and effective
algorithm for computing Bayes factor in a wide range of problems using draws from posterior distributions
generated by standard Bayesian programs such as BUGS, JAGS and Stan. The tedious and error-prone
task of coding custom-made software specific for Bayes factor is then avoided.
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1 Introduction
Hypothesis testing is widely used in scientific research. For a statistical model parameterized in parameter
θ, the general formulation is:
H0 ∶ θ ∈ Θ0 vs H1 ∶ θ ∈ Θ1.
Traditionally, a point null hypothesis takes Θ0 to be a single point θ0 leading to the following
H0 ∶ θ = θ0 vs H1 ∶ θ ≠ θ0.
However, many researchers, such as Meehl (1978) and Cohen (1994), have argued that such formulation is
not appropriate in most scientific researches because the parameter θ cannot be exactly specified to a single
point θ0. For example when comparing a new treatment with a standard one, the differences in the mean of
an outcome variable, say θ, is almost never exactly 0. Therefore a more appropriate formulation is
H0 ∶ ∥θ − θ0∥ ≤ δ
H1 ∶ ∥θ − θ0∥ > δ,
where θ that satisfies ∥θ − θ0∥ ≤ δ represents practically negligible deviation from θ0. For example, Lakens
et al. (2018) and Lakens (2017) use this approach to study if there is a pre-specified meaningful treatment
effect in gerontology and clinical trials. Morey and Rouder (2011) reviews and develops interval null hy-
pothesis testing in the context of psychological research.
The frequentist approach to interval null hypothesis testing is to conduct an equivalence test (e.g. Lak-
ens, 2017; Rogers et al., 1993; Wellek, 2010). The limitation of the frequentist hypothesis testing is well
documented (Wasserstein et al., 2016). In particular, it can only quantify evidence against the default hy-
pothesis but not the evidence for it. Recently, there have been renewed interests (Harms and Lakens, 2018;
Lakens et al., 2018; Morey and Rouder, 2011; Kruschke, 2013) in using a Bayesian approach for tackling
this interval null hypothesis problem so that H0 and H1 can be treated on a more equal basis. The stan-
dard Bayes approach is to use Bayes factor to quantify the relative support of the data for one hypothesis
over the other. Standard references for Bayes factor include Kass and Wasserman (1995); Berger (2013);
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Berger and Pericchi (1996); Berger et al. (2001); Berger and Pericchi (2015). The special issue of Journal
of Mathematical Psychology (June, 2016) provides in-depth and updated discussion of Bayes Factor.
Alternatively, Krushke and others (Kruschke, 2018, 2011, 2013, 2014; Carlin and Louis, 2008; Edwards
and Berry, 2010; Freedman et al., 1984; Hobbs and Carlin, 2007) have championed a procedure called ROPE
(region of practical equivalence), in which the interval null is treated as a region of practical equivalence.
In this procedure, the 1-α highest density interval of the posterior distribution of θ is constructed. If this
interval falls completely in Θj , either j = 0 or j = 1, then Hj is selected. Otherwise, the selection between
H0 and H1 is declared uncertain.
The Bayes factor and ROPE have been treated as two different and distinctive procedures. In this pa-
per, we provide a formal connection between them in Lemma 1 with two benefits. First, it helps to better
understand and improve the the ROPE procedure. Secondly and more importantly, it leads to a simple and
effective algorithm for computing Bayes factor in a wide range of problems by using posterior draws gen-
erated by standard Bayesian software programs such as WinBUGS (Lunn et al., 2000), JAGS (Kurt Hornik
and Zeileis, 2003), and Stan (Carpenter et al., 2017). This circumvents the need for custom-made software
to calculate marginal distributions for the Bayes factors.
2 Connection between Bayes factor and the posterior distribution
We first outline the Bayes factor approach in testing H0 vs. H1. We need first to specify a prior of θ under
H0, pi0 on Θ0, and a prior of θ underH1, pi1 on Θ1. Let f(y ∣ θ) be the likelihood. The marginal distribution
of y under Hj is then,
f(y ∣ pij) = ∫ f(y ∣ θ)pij(θ)dθ, for j = 0,1.
Here we use notation f(y ∣ pij) to emphasize the dependence of marginal density on on prior pij . Further
assume that the prior probability is η1 for for H1 and 1− η1 for H0. It follows directly from Bayes Theorem
that
Pr(θ ∼ pi1 ∣ y)
1 −Pr(θ ∼ pi1 ∣ y) = f(y ∣ pi1)f(y ∣ pi0) η11 − η1 , (1)
where Pr(θ ∼ pi1 ∣ y) denotes the posterior probability that θ was generated from pi1.
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The term f(y∣pi1)
f(y∣pi0) is called the Bayes Factor, which quantifies the relative support in data for θ ∼ pi1 over
θ ∼ pi0, independent of η1. For interval null hypothesis, the Bayes factor and the posterior probability of θ
are closely related as shown in Lemma 1.
Lemma 1. Assume that Θ is the disjoint union of Θ0 and Θ1 and pi0(θ) = 0 for θ ∈ Θ1 and pi1(θ) = 0 for
θ ∈ Θ0. Let η1 = Pr(H1) as defined before and define the combined prior of θ on Θ to be
pi = (1 − η1)pi0 + η1pi1. (2)
Let f(y ∣ θ) be the likelihood, and let f(θ ∣ y) be the posterior density of θ under pi. Then
Pr(θ ∼ pi1 ∣ y) = ∫
Θ1
f(θ ∣ y)dθ
and therefore
Bayes factor ≜ f(y ∣ pi1)
f(y ∣ pi0) = 1 − η1η1 Pr(θ ∼ pi1 ∣ y)1 −Pr(θ ∼ pi1 ∣ y) .
Proof.
∫
Θ1
f(θ ∣ y)dθ = ∫Θ1 {(1 − η1)pi0(θ) + η1pi1(θ)} f(y ∣ θ)dθ∫Θ pi(θ)f(y ∣ θ)dθ
= η1 ∫Θ1 pi1(θ)f(y ∣ θ)dθ
η1 ∫Θ1 pi1(θ)f(y ∣ θ)dθ + (1 − η1) ∫Θ0 pi0(θ)f(y ∣ θ)dθ= Pr(θ ∼ pi1 ∣ y),
which is the first expression of the Lemma. The second expression on Bayes factor follows from this result
and (1).
Although Lemma 1 is straightforward, it does not appear to have been published before. The two impor-
tant implications of this Lemma are discussed in the next two sections.
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3 The ROPE Procedure
In ROPE procedure, a prior distribution pi is directly specified for parameter θ on Θ. The posterior distribu-
tion of θ is then computed. Kruschke (2018) summarized the ROPE procedure as follows.
“Consider a ROPE around a null value of a parameter. If the 95% HDI [Highest Density
Interval] of the parameter distribution falls completely outside the ROPE then reject the null
value, because the 95% most credible values of the parameter are all not practically equivalent
to the null value. If the 95% HDI of the parameter distribution falls completely inside the ROPE
then accept the null value for practical purposes, because the 95% most credible values of the
parameter are all practically equivalent to the null value. Otherwise remain undecided, because
some of the most credible values are practically equivalent to the null while other of the most
credible values are not.”
The highest density interval (HDI) is used in ROPE because it is the (1−α) credible interval of shortest
length/smallest volume. This approach has a strong intuitive appeal and is similar to the frequentist equiv-
alence testing (e.g., Lakens (2017); Rogers et al. (1993); Wellek (2010)) in which a (1 − α) confidence
interval is used in place of the (1 − α) highest density interval.
We now provide additional details of the ROPE procedure. First, ROPE declares undecided between H0
and H1 when the (1 − α) HDI is contained in neither Θ0 nor Θ1. This, however, is not fully informative
as it fails to distinguish between two different cases: (1) the HDI is almost contained in Θ0 (or alternatively
in Θ1); (2) the HDI is spread more evenly between Θ0 and Θ1. To improve on this, note that Pr(θ ∼ pij ∣
y) ≥ (1 − α) if any (1 − α) credible interval is contained in Θj for j = 0 or j = 1. Therefore, we propose
to directly report Pr(θ ∼ pij ∣ y) with a decision rule to declare for Hj when Pr(θ ∼ pij ∣ y) > 1 − α. For
the two cases above, Pr(θ ∼ pi0 ∣ y) is close to 1 − α for Case 1 but it is close to 0.5 for Case 2, which is
more informative. In addition, Pr(θ ∼ pij ∣ y) connects ROPE directly to Bayes factor as seen in Lemma 1.
Reporting Pr(θ ∈ Θj ∣ y) = Pr(θ ∼ pij ∣ y) was also proposed in Wellek (2010) but Kruschke (2018) seems
to reject this idea in favor of using HDI. Our analysis provides additional support for using Pr(θ ∼ pij ∣ y)
instead of HDI.
Second, Kruschke and others have touted the greater robustness of ROPE to prior pi. Here we refor-
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mulate the ROPE procedure in a mathematically equivalent way so that it more closely resembles a Bayes
factor formulation. ROPE procedure starts with a single prior distribution, pi, on Θ, but by truncating this
distribution on Θ0 and Θ1, respectively, we arrive at priors pi0 and pi1 along with η1, the prior probability of
Θ0. More specifically, we have
pi0(θ) = pi(θ)∫Θ0 pi(θ)dθ for θ ∈ Θ0
pi1(θ) = pi(θ)∫Θ1 pi(θ)dθ for θ ∈ Θ1
η1 = ∫
Θ1
pi(θ)dθ.
This allows us to explore the greater robustness of the ROPE procedure over the Bayes factor approach. As
an example, consider the hypotheses H0 ∶ ∣θ∣ ≤ δ vs H1 ∶ ∣θ∣ > δ, and let pi ≜ N(0, τ2). As τ → ∞, pi0
approaches unif(−δ, δ) and pi1 becomes more and more diffused on (−∞,−δ) ∪ (δ,∞). It is well known
from Lindley’s paradox that a very diffuse pi1 leads to increased support for H0 over H1 (Robert, 2014).
However at the same time, η1 → 1, which compensates for the more diffused pi1 as seen from Equation 1.
This accounts for the apparent greater robustness of the ROPE procedure. Although the greater robustness
is generally desirable, this implicit tangling of pi0, pi1 and η1 can be difficult to comprehend for many
statisticians. How to specify these quantities in a more meaningful way remains a topic for further research.
4 Computing Bayes factors using MCMC draws from the posterior
distribution
Bayes factor usually requires custom software to compute the marginal distributions f(y ∣ pi1) and f(y ∣ pi0)
through numerical integration. Coding such software can be a tedious and error-prone task. Lemma 1,
however, provides a simple way to compute Bayes factor using standard Bayesian programs for drawing
from posterior distribution such as Stan (Carpenter et al., 2017), JAGS (Kurt Hornik and Zeileis, 2003), and
WinBUGS (Lunn et al., 2000). Let θ(1), . . . , θ(N) be draws from posterior distribution p(θ ∣ y) under prior
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pi in Equation (2), where N is the Monte Carlo sample size. Then under general conditions,
1
N
N∑
i=1 1θ(i)∈Θ1
N→∞Ð→ Pr(θ ∼ pi1 ∣ y)
and
1 − η1
η1
1
N ∑Ni=1 1θ(i)∈Θ1
1 − 1
N ∑Ni=1 1θ(i)∈Θ1 N→∞Ð→ BF = f(y ∣ pi1)f(y ∣ pi0) . (3)
There are several advantages of this approach of computing Bayes factor compared to custom software.
First, it reduces programming cost considerably. Second, packages such as Stan (Carpenter et al., 2017),
JAGS (Kurt Hornik and Zeileis, 2003), and WinBUGS (Lunn et al., 2000) are well-tested, high quality
software routines that are familiar to most statisticians performing Bayesian analyses. So it is more likely
to get correct answers quickly. Third, people have gained considerable experience and understanding of
the posterior distribution, and this approach facilitates the adoption of Bayes factor as an integrated part of
Bayesian inference. The disadvantage is that it can be computationally less efficient than custom software
specifically designed for Bayes factor.
Bayes factor does not depend on the value of η1. In fact, (3) holds for for any 0 < η1 < 1. However,
based on our experience, the computational efficiency of drawing Monte Carlo samples from the posterior
distribution can be greatly improved when η1 is chosen so that the combined prior pi in Equation (2) is made
more continuous at the boundary between Θ0 and Θ1.
Note that Using MCMC draws to compute Bayes factor has been discussed previously. For example,
Morey et al. (2011) discusses using improved Savage-Dickey method to compute Bayes for nested models.
Weinberg et al. (2012) in a more general setting, proposes the use of harmonic mean approximation and
other methods for computing the marginal distributions. Our method, by utilizing the special structure of
interval hypotheses, is much simpler.
We demonstrate our methods in the following two two examples.
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4.1 Example 1: Two sample t-test
Here we consider a simple dataset from Lyle et al. (1987), which has also been analyzed in Go¨nen et al.
(2005) and Wang and Liu (2016). The data (reproduced in Table 1) consists of changes in systolic blood
pressure over 12 weeks for 21 African-American men, 10 of whom took calcium supplements and the
remaining 11 took placebo supplements. Testing for equality of means between these two groups with a
two-sample t-test (assuming equality of variances) yields a t-statistic of 1.63 and a p-value of 0.12.
Table 1: Blood pressure change data from Lyle et al. (1987).
calcium 7 -4 18 17 -3 -5 1 10 11 -2
placebo -1 12 -1 -3 3 -5 5 2 -11 -1 -3
We now proceed to analyze the data using the interval null hypothesis Bayes factor. Let X1, . . . ,Xn
iid∼N (µX , σ2), and let Y1, . . . , Ym iid∼ N (µY , σ2). We are interested in evaluating the standardized effect size
θ = µY − µX
σ
.
In particular, we consider the following hypotheses:
H0 ∶ ∣θ∣ ≤ δ
H1 ∶ ∣θ∣ > δ,
for some pre-specified δ > 0. To compute Bayes factor, we assume the following priors
µX ∼ N (0,1002)
σ2 ∼ Inverse-Gamma(10−2,10−2)
θ ∣H0 ≜ pi0(θ) ∼ Uniform(−δ, δ)
θ ∣H1 ≜ pi1(θ) ∼ N(0, τ2)I∣θ∣>δ,
where τ in θ ∈ H1 is a parameter to be specified. Note that a larger τ corresponds to a prior distribution
θ ∈ H1 that is more deviated from θ ∣ H0. Let η0 = Pr(H0) be the prior for hypothesis H0. The combined
prior pi for θ is then (2) in Lemma 1. Given the above priors for µA, σ2 and θ and the likelihoods, we utilize
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Stan to generate draws θ(1), . . . , θ(N) from the posterior distribution of θ. We then use Equation (3) for a
consistent estimator of the Bayes factor.
We calculate Bayes factor of H1 over H0 for δ = 0.1, which is generally considered a small effect size,
over a range of values for τ in the prior for θ ∣ H1 that reflects different deviations of H1 from H0. The
result is plotted in Figure 1. All these Bayes factors are between 1 and 1.4, indicating slightly more support
of H1 over H0.
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Figure 1: Bayes factors for the blood pressure data.
It is noted that the Bayes factor for two-sample t-test setting with point null H0 ∶ µX − µY = 0 has been
extensively studied (Rouder et al., 2009; Wang and Liu, 2016; Go¨nen et al., 2005) including the R package
BayesFactor by Morey and Rouder (2018).
4.2 Example 2: Meta analysis with a hierarchical Bayes model
Here we will consider meta analysis of a dataset originally published in Table 10 of Yusuf et al. (1985), which
contains mortality data across 22 studies of patients who were treated with either a beta-blocker (treatment
group) or placebo (control group) after experiencing a heart attack. The dataset is also reproduced and
analyzed in (Gelman et al., 2013, Sec. 5.6). The data from each study forms a 2 × 2 table and the variables
for the ith study are summarized in Table 2.
Table 2: Data format for the ith study
death non-death total
beta-blocker yi,1 ni,1 − yi,1 ni,1
placebo yi,0 ni,0 − yi,0 ni,0
For the ith study, let pi,j , j = 0,1, be the underlying probability of death for the beta-blocker and placebo
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group respectively, and let θi be the corresponding log odds ratio; i.e.
θi = log( pi,1
1 − pi,1 / pi,01 − pi,0 ) = logit(pi,1) − logit(pi,0).
We assume θi ∼ N (θ, σ2) and the focus of our inference is θ, the mean of individual θi. In particular, we
compare H0 ∶ ∣θ∣ ≤ δ vs. H1 ∶ ∣θ∣ > δ. Our hierarchical Bayesian model is specified as follows:
yi,j ∼ Binomial(ni,j , pi,j)
logit(pi,0) ∼ N (0,102)
θi ∼ N (θ, σ2)
θ ∣H0 ≜ pi0 ∼ Uniform[−δ, δ]
θ ∣H1 ≜ pi1 ∼ N(0, τ2)I∣θ∣>δ
σ2 ∼ Inverse-Gamma(10−2,10−2).
For τ = 1.5δ and η0 = 1/2, we draw MCMC samples from the posterior of θ using Stan and estimate
Pr(θ ∈ pi1 ∣ y) and BF10 (Bayes Factor of H1 over H0) as in Lemma 1. The results are given in Table 3 for
three different values of effect size δ. Note that here the Bayes factor shows strong support for pi1 over pi0
for δ = 0.1 whereas it shows a weak support of pi1 for δ = 0.2. When δ is increased to 0.3, however, Bayes
factor shows weak support of pi0 over pi1.
Table 3: Bayes factors for different values of δ
δ Pr(θ ∈ pi1 ∣ y) BF10
0.1 0.97 35.6
0.2 0.81 4.37
0.3 0.29 0.411
Stan and R code for Examples 1 and 2 are available at https://sites.google.com/site/jiangangliao.
In Summary, this papers establishes a formal connection between ROPE and Bayes factor for comparing
interval hypotheses. This connection leads to better understanding of ROPE and provides a simple method
to compute Bayes factor using MCMC draws from the posterior distribution.
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